Computational screening of FDA-approved drugs to identify potential TgDHFR, TgPRS, and TgCDPK1 proteins inhibitors against Toxoplasma gondii
Abstract Toxoplasma gondii (T. gondii) is one of the most successful parasites in the world, because about a third of the world's population is seropositive for toxoplasmosis. Treatment regimens for toxoplasmosis have remained unchanged for the past 20 years, and no new drugs have been introduc...
Main Authors: | Zahra Gharibi, Behzad Shahbazi, Hamed Gouklani, Hoda Nassira, Zahra Rezaei, Khadijeh Ahmadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-32388-9 |
Similar Items
-
Immune responses and protection after DNA vaccination against Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2)
by: Chen Kai, et al.
Published: (2017-01-01) -
The role of toxoplasma gondii (Tg) in schizophrenia: serofrequency and serointensity of Tg / Nor Fatini Adam
by: Adam, Nor Fatini
Published: (2015) -
Protective immunity induced by DNA vaccine containing TgGRA35, TgGRA42, and TgGRA43 against Toxoplasma gondii infection in Kunming mice
by: Youbo Shi, et al.
Published: (2023-10-01) -
Evaluation of immune protection against Toxoplasma gondii infection in mice induced by a multi-antigenic DNA vaccine containing TgGRA24, TgGRA25 and TgMIC6
by: Xu Xiao-Pei, et al.
Published: (2019-01-01) -
Pularek Tg. Pengelih /
by: Universiti Teknologi Malaysia Perpustakaan 3383